- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01995630
Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients
June 27, 2017 updated by: Navid Ardjomand, Medical University of Graz
Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients: A Randomized Clinical Trial
The purpose of this study is to evaluate differences in the depth of focus after implantation of a spherical or aspheric IOL in hypermetropic and emmetropic patients.
After implantation of a spherical IOL hypermetropic patients may achieve a better depth of focus compared to emmetropic patients due to a larger amount of spherical aberrations.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Graz, Austria, 8036
- Dept. of Ophthalmology, Medical University of Graz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cataract
- Dioptric power of IOL >22.0 D in hypermetropic patients and 18.0-22.0 D in emmetropic patients, respectively
Exclusion Criteria:
- Uveitis, pathology of the retina or the optic nerve
- Corneal scarring or irregularities
- Astigmatism >1.5 D
- Amblyopia
- Perioperative complications
- Postoperative refractive error >2.0 D of spherical equivalent
- Postoperative DCVA <0.8 (ETDRS)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hypermetropic, spherical IOL
AMO Sensar AR40e
|
|
Experimental: Hypermetropic, aspheric IOL
AMO Tecnis ZA9003
|
|
Active Comparator: Emmetropic, spherical IOL
AMO Sensar AR40e
|
|
Active Comparator: Emmetropic, aspheric IOL
AMO Tecnis ZA9003
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Distance-corrected intermediate visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Distance-corrected near visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Uncorrected distance visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Corrected distance visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Uncorrected near visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Corrected near visual acuity
Time Frame: 3 month postop
|
3 month postop
|
Pseudoaccomodation
Time Frame: 3 month postop
|
3 month postop
|
Photopic contrast sensitivity
Time Frame: 3 month postop
|
3 month postop
|
Mesopic contrast sensitivity
Time Frame: 3 month postop
|
3 month postop
|
Spherical aberrations
Time Frame: 3 month postop
|
3 month postop
|
High order aberrations
Time Frame: 3 month postop
|
3 month postop
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Navid Ardjomand, MD, Dept. of Ophthalmology, Medical University of Graz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 26, 2016
Study Registration Dates
First Submitted
November 21, 2013
First Submitted That Met QC Criteria
November 21, 2013
First Posted (Estimate)
November 26, 2013
Study Record Updates
Last Update Posted (Actual)
June 28, 2017
Last Update Submitted That Met QC Criteria
June 27, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIOLvsAIOL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on AMO Sensar AR40e
-
Parc de Salut MarCompletedCataract Senile | Lenses, Intraocular
-
University Hospital, AngersCompletedObstructive Sleep Apnea SyndromeFrance
-
Alexander KolevzonCompletedEpilepsy | Phelan-McDermid SyndromeUnited States
-
Queen's UniversityWithdrawnCataracts | Fuch's Endothelial DystrophyCanada
-
Durrie VisionAlcon ResearchCompletedAstigmatism | MyopiaUnited States
-
Intuor Technologies, Inc.Abbott Medical OpticsCompletedCataract SurgeryUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Stanford UniversityCompletedAstigmatism | MyopiaUnited States
-
University of TorontoKensington Eye InstituteTerminatedCataracts | Visual Acuity Reduced Transiently | Loss of Visual Contrast Sensitivity | Functional Visual LossCanada
-
National Taiwan University HospitalCompleted